InsiderClue
Insiders · Profile

Burrows Scott L

Chief Financial Officer at Spyre Therapeutics · Chief Financial Officer at Arcutis Biotherapeutics. Filing since 27 Dec 2021. CIK 0001853327

SYRE Spyre Therapeutics, Inc. Chief Financial Officer · 13 trades ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE Spyre Therapeutics, Inc.
1 Oct 2026
Chief Financial Officer
Sold on a plan
7,500
$688.76K
8.6%
SYRE Spyre Therapeutics, Inc.
30 Sep 2026
Chief Financial Officer
Sold on a plan
17,500
$1.57M
18.0%
SYRE Spyre Therapeutics, Inc.
2 Sep 2026
Chief Financial Officer
Sold on a plan
18,232
$1.63M
18.6%
SYRE Spyre Therapeutics, Inc.
1 Sep 2026
Chief Financial Officer
Sold on a plan
7,500
$654.79K
7.1%
SYRE Spyre Therapeutics, Inc.
3 Aug 2026
Chief Financial Officer
Sold on a plan
7,500
$716.77K
7.1%
SYRE Spyre Therapeutics, Inc.
1 Jul 2026
Chief Financial Officer
Sold on a plan
7,500
$658.04K
7.1%
SYRE Spyre Therapeutics, Inc.
25 Jun 2026
Chief Financial Officer
Sold at will
15,000
$1.31M
13.3%
SYRE Spyre Therapeutics, Inc.
1 Jun 2026
Chief Financial Officer
Sold on a plan
7,500
$532.94K
7.1%
SYRE Spyre Therapeutics, Inc.
1 May 2026
Chief Financial Officer
Sold on a plan
12,500
$892.13K
11.3%
SYRE Spyre Therapeutics, Inc.
1 Apr 2026
Chief Financial Officer
Sold on a plan
7,500
$370.08K
7.1%
SYRE Spyre Therapeutics, Inc.
3 Mar 2026
Chief Financial Officer
Sold on a plan
2,500
$101.62K
2.5%
SYRE Spyre Therapeutics, Inc.
2 Sep 2025
Chief Financial Officer
Sold at will
18,428
$299.64K
15.8%
SYRE Spyre Therapeutics, Inc.
3 Sep 2024
Chief Financial Officer
Sold at will
18,531
$522.07K
13.7%
ARQT Arcutis Biotherapeutics, Inc.
6 Mar 2023
Chief Financial Officer
Sold, plan not stated
291
$4.44K
0.5%
ARQT Arcutis Biotherapeutics, Inc.
2 Mar 2023
Chief Financial Officer
Sold, plan not stated
1,434
$22.70K
3.6%
ARQT Arcutis Biotherapeutics, Inc.
28 Feb 2023
Chief Financial Officer
Sold, plan not stated
416
$6.73K
1.0%
ARQT Arcutis Biotherapeutics, Inc.
7 Mar 2022
Chief Financial Officer
Sold, plan not stated
10
$164.45
0.0%
ARQT Arcutis Biotherapeutics, Inc.
4 Mar 2022
Chief Financial Officer
Sold, plan not stated
293
$4.94K
0.8%
ARQT Arcutis Biotherapeutics, Inc.
1 Mar 2022
Chief Financial Officer
Sold, plan not stated
420
$7.46K
1.9%
ARQT Arcutis Biotherapeutics, Inc.
27 Dec 2021
Chief Financial Officer
Sold, plan not stated
12,560
$252.14K
35.6%
20 decisions on file.